Table 1.
Descriptive statistics – number of observations and incidence
| All (N) | Not Post-COVID (N) | Post-COVID (N) | Incidence of post-COVID condition within the respective predictor % (95% confidence interval) | |
|---|---|---|---|---|
| All (baseline incidence risk) | 214,667 | 213,759 | 908 | 0.42% [0.4%–0.45%] |
| Male | 107,123 | 106,837 | 286 | 0.27% [0.24%–0.3%] |
| Female | 107,544 | 106,922 | 622 | 0.58% [0.53%–0.62%] |
| Non-Immigrant | 147,072 | 146,358 | 714 | 0.49% [0.45%–0.52%] |
| Immigrant | 67,595 | 67,401 | 194 | 0.29% [0.25%–0.33%] |
| Age group [30,40] | 85,473 | 85,151 | 322 | 0.38% [0.34%–0.42%] |
| Age group 〈40,50] | 70,751 | 70,425 | 326 | 0.46% [0.41%–0.51%] |
| Age group 〈50,60] | 41,426 | 41,223 | 203 | 0.49% [0.42%–0.56%] |
| Age group 〈60,70] | 17,017 | 16,960 | 57 | 0.33% [0.25%–0.42%] |
| Education: Primary | 42,750 | 42,610 | 140 | 0.33% [0.27%–0.38%] |
| Education: Secondary | 73,980 | 73,683 | 297 | 0.4% [0.36%–0.45%] |
| Education: Low Uni | 65,045 | 64,684 | 361 | 0.56% [0.5%–0.61%] |
| Education: High Uni | 32,892 | 32,782 | 110 | 0.33% [0.27%–0.4%] |
| Income percentile 〈0,20] | 41,944 | 41,838 | 106 | 0.25% [0.2%–0.3%] |
| Income percentile 〈20,40] | 41,090 | 40,937 | 153 | 0.37% [0.31%–0.43%] |
| Income percentile 〈40,60] | 43,654 | 43,414 | 240 | 0.55% [0.48%–0.62%] |
| Income percentile 〈60,80] | 43,711 | 43,478 | 233 | 0.53% [0.46%–0.6%] |
| Income percentile 〈80,100] | 44,268 | 44,092 | 176 | 0.4% [0.34%–0.46%] |
| Virus and vaccine | ||||
| Vaccinea | 150,281 | 149,882 | 399 | 0.27% [0.24%–0.29%] |
| Wuhan virus | 22,945 | 22,653 | 292 | 1.27% [1.13%–1.42%] |
| Alpha virus | 22,508 | 22,347 | 161 | 0.72% [0.61%–0.83%] |
| Delta virus | 78,518 | 78,171 | 347 | 0.44% [0.4%–0.49%] |
| Omicron virus | 90,696 | 90,588 | 108 | 0.12% [0.1%–0.14%] |
| Healthcare utilization 2017–2019 | ||||
| General and Unspecified (A) | 28,649 | 28,454 | 195 | 0.68% [0.59%–0.78%] |
| Blood, Blood Forming Organs and Immune Mechanism (B) | 2988 | 2974 | 14 | 0.47% [0.22%–0.71%] |
| Digestive (D) | 30,536 | 30,337 | 199 | 0.65% [0.56%–0.74%] |
| Eye (F) | 8326 | 8273 | 53 | 0.64% [0.47%–0.81%] |
| Ear (H) | 7059 | 7024 | 35 | 0.5% [0.33%–0.66%] |
| Cardiovascular (K) | 20,464 | 20,357 | 107 | 0.52% [0.42%–0.62%] |
| Musculoskeletal (L) | 77,854 | 77,408 | 446 | 0.57% [0.52%–0.63%] |
| Neurological (N) | 18,942 | 18,817 | 125 | 0.66% [0.54%–0.78%] |
| Psychological (P) | 39,166 | 38,875 | 291 | 0.74% [0.66%–0.83%] |
| Respiratory (R) | 53,527 | 53,162 | 365 | 0.68% [0.61%–0.75%] |
| Skin (S) | 32,719 | 32,543 | 176 | 0.54% [0.46%–0.62%] |
| Metabolic and Nutritional (T) | 20,594 | 20,485 | 109 | 0.53% [0.43%–0.63%] |
aThe share vaccinated at least once. This rate varied considerably across the different virus types. In Supplementary Table 3 we therefore also present incidences separately among vaccinated and unvaccinated for each virus type.